Form 10-Q WINDTREE THERAPEUTICS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
Windtree Therapeutics (WINT) Misses Q1 EPS by 12c
May 12, 2016 7:21 AM EDTWindtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.
For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.
... More